Leap Therapeutics And MacroGenics Among Early Winners And Losers At ESMO

Contrasting Market Reception For Rivals In GI Cancer

 
• By Andrew McConaghie
  
Concerns about safety and tough competition in the oncology market weighed on MacroGenics shares.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip